MARKET

TRIB

TRIB

Trinity Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9336
-0.0415
-4.26%
Opening 10:57 04/06 EDT
OPEN
0.9680
PREV CLOSE
0.9751
HIGH
1.000
LOW
0.9100
VOLUME
169.71K
TURNOVER
--
52 WEEK HIGH
3.222
52 WEEK LOW
0.5610
MARKET CAP
22.44M
P/E (TTM)
-0.6480
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TRIB stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.

EPS

TRIB News

More
  • Edited Transcript of TRIB earnings conference call or presentation 31-Mar-20 3:00pm GMT
  • Thomson Reuters StreetEvents · 2d ago
  • Should You Be Concerned About Trinity Biotech plc's (NASDAQ:TRIB) Historical Volatility?
  • Simply Wall St. · 4d ago
  • FDA OKs emergency use of 2-minute coronavirus test
  • seekingalpha · 5d ago
  • Trinity Biotech plc's (TRIB) CEO Ronan O'Caoimh on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 5d ago

Industry

Medical Equipment, Supplies & Distribution
+3.59%
Healthcare Equipment & Supplies
+4.14%

Hot Stocks

Symbol
Price
%Change

About TRIB

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.
More

Webull offers kinds of Trinity Biotech plc (ADR) stock information, including NASDAQ:TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions.